Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2007
11/14/2007EP1853293A1 Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease
11/14/2007EP1853285A2 Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia
11/14/2007EP1853268A1 Use of sodium channel blockers and their analogues for the treatment of nicotine dependency
11/14/2007EP1853266A1 Methods and compositions for treating diabetes, metabolic syndrome and other conditions
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1853254A1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids
11/14/2007EP1853241A1 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3- cyclohexanedione in the treatment of parkinson's disease
11/14/2007EP1853235A1 Methods for improving drug disposition
11/14/2007EP1853232A1 Stable crystalline form of bifeprunox mesylate, dosage forms thereof adn methods for using them
11/14/2007EP1853230A2 Dosage form and method for sustained release of a substituted pyrazine compound
11/14/2007EP1716147B1 Diaza-spiropiperidine derivatives as inhibitors of glycine transporter 1 and glycine transporter 2
11/14/2007EP1668003B1 Benzisoxazoles
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1469835B1 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007EP1423012B1 Medical use of stem cells expressing vegfr-1
11/14/2007EP1393637B1 Use of palatinose for sustaining mental concentration and attentiveness
11/14/2007EP1387698B1 Method of preventing cell death using antibodies to neural thread proteins
11/14/2007EP1383507B1 Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances
11/14/2007EP1373503B1 Neurotrophic factors
11/14/2007EP1368048B1 Pharmaceutical composition made of cannabis extracts
11/14/2007EP1368021B1 Carbamate compounds for use in preventing or treating bipolar disorder
11/14/2007EP1294659B1 Process for isolating enantiomers of cetamine
11/14/2007EP1244435B1 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
11/14/2007EP1235592B1 Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament
11/14/2007EP1212086B1 Immunological tolerance-induction agent
11/14/2007EP1181042B1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
11/14/2007EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof
11/14/2007EP1114156B1 Mammalian transforming growth factor beta - 9 (ztgfss9)
11/14/2007CN101072815A Polymeric polphenol extracted for fermented tea, therapeutic agent for mitochondrial disease, preventive/therapeutic agent for diabetes mellitus, and food or beverage
11/14/2007CN101072784A Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them
11/14/2007CN101072774A Enantiomers of 3-heteroaryl-8h-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors
11/14/2007CN101072771A Cgrp受体拮抗剂 Cgrp receptor antagonists
11/14/2007CN101072770A Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
11/14/2007CN101072768A 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of CNS disorders
11/14/2007CN101072765A Phenylpiperazines with a combination of affinity for dopamine -D2 receptors and serotonin reuptake sites
11/14/2007CN101072760A Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease
11/14/2007CN101072563A Benzdioxane piperazine derivatives with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites
11/14/2007CN101072560A Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
11/14/2007CN101072559A Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
11/14/2007CN101072558A Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
11/14/2007CN101072509A Treatment and prevention of inflammatory disorders
11/14/2007CN101070550A Method for preparing krev alcohol and use for preparing anti-acetylcholinesterase medicine
11/14/2007CN101070338A Tanshinone IIA potassium sulfonate used for preparing medicine for preventing and treating cerebral ischemia and cerebral anoxia and myocardial ischemia and myocardio anoxia
11/14/2007CN101070323A Porphyrin derivative, its preparing method and use of same as small-molecular anti-oxidation agent
11/14/2007CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/14/2007CN101069742A Pancreatic kininogenase tablet and preparing method
11/14/2007CN101069734A Chinese medicine composition for vascular cretinism and preparing method therefor
11/14/2007CN101069699A Bone-tonifying pills for promoting bone growth
11/14/2007CN101069561A Edible brain nutrient essence
11/14/2007CN101069555A Kudzuvine root areca and making method
11/14/2007CN101069532A Blended oil in which the ratio of linoleic acid and linolenic acid is 4:1
11/14/2007CN100348600C Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of growth hormone release inhibiting factor receptors
11/14/2007CN100348598C Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
11/14/2007CN100348591C Substituted methylene pyrones derivatives and their preparing process and use
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/14/2007CN100348584C 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
11/14/2007CN100348265C Controlled release composition and method of producing the same
11/14/2007CN100348237C Chinese medicine for improving memory and its preparation method
11/14/2007CN100348230C Smoking stopping method
11/14/2007CN100348228C New use of powder for regulating liver and spleen and its active part
11/14/2007CN100348218C Composition comprising the extract of cistanche deserticola Y.C. ma showing enhancing activity of the neurite outgrowth and neurotrophic effects
11/14/2007CN100348201C Methy cobalamine dispersion tablet and preparing method
11/14/2007CN100348200C Medicinal use of paeoniflorin
11/14/2007CN100348198C Monosialic acid tetrahexose ganglioside liposome complex preparation
11/14/2007CN100348180C Oral disintegration tablet of tramadol hydrochloride and preparation method
11/14/2007CN100348172C Notoginseng floral leaf drop pill in use for cleaning away heat and its prepn. process
11/14/2007CN100348170C Yitongshu drop pill for treating pain and its preparation method
11/13/2007US7294720 N3-(hydroxy- or alkoxyphenyl) amidrazone, e.g., N3-[3-Methoxyphenyl]-p-tert-butyl-benzamidrazone, are intermediates for preparing phenyl-1,2,4-triazoles, e.g., 1-{3-[4-(tert-Butyl)phenyl]-(1,2,4-triazol-4-yl)}-3-methoxybenzene
11/13/2007US7294710 High-affinity choline transporter
11/13/2007US7294697 Short chain neurotoxin from sea snake-Lapemis hardwickii and genes encoding the neurotoxin
11/13/2007US7294652 Autoimmune conditions and NADPH oxidase defects
11/13/2007US7294648 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof
11/13/2007US7294647 Kappa agonist compounds and pharmaceutical formulations thereof
11/13/2007US7294646 Indole diterpene natural product and synthetic compound; Potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions related to elevated intraocular pressure in the eye
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007US7294638 Treatment of ADHD
11/13/2007US7294637 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction
11/13/2007US7294632 E.g., 1'-[(2S)-2-Hydroxy-2-phenylethyl]-8'-pyridin-4-yl-3',4'-dihydrospiro[cyclopropane-1,2'-pyrimido[1,2-a]pyrimidin]-6'(1'H)-one; treating non-insulin dependent diabetes
11/13/2007US7294630 Piperazinyl piperidine tachykinin antagonists
11/13/2007US7294628 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
11/13/2007US7294625 Pyrazole compounds
11/13/2007US7294624 Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
11/13/2007US7294623 Benzyl morpholine derivatives
11/13/2007US7294622 Lactams and uses thereof
11/13/2007US7294480 High throughput screening assays using fatty acid synthetic enzymes
11/13/2007US7294476 Testing a compound for the ability to inhibit PKG I alpha; testing the compound for the ability to inhibit PKG I beta; identifying the compound as a candidate drug useful in the treatment of pain ifit selectively inhibits PKG I alpha relative to PKG I beta .
11/13/2007US7294472 Method for identifying modulators of G protein coupled receptor signaling
11/13/2007US7294345 Otorhinological delivery device
11/13/2007US7294339 Method for treating allodynia by peripheral administration of a neurotoxin
11/13/2007CA2402707C Use of cdp-choline for the treatment of alcohol withdrawal syndrome
11/13/2007CA2352544C Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture of a medicament for the treatment of glycolipid storage diseases
11/13/2007CA2278422C D-methadone, a nonopioid analgesic
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/13/2007CA2209904C Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity
11/13/2007CA2157859C Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
11/13/2007CA2157856C Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/13/2007CA2006813C Purified ciliary neurotrophic factor
11/08/2007WO2007127475A2 Pyridazines for demyelinating diseases and neuropathic pain
11/08/2007WO2007127474A2 Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
1 ... 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 ... 1833